REsponsive theranostic nanosystems for Advanced Cancer Treatment

Project Information

REACT

Grant agreement ID: 758887

DOI 10.3030/758887

EC signature date 13 August 2018

Start date 1 January 2019

End date 31 December 2024

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 1 498 345,77

EU contribution € 1 498 345,77

Coordinated by

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Ireland

Publications

Peer reviewed articles (3)

Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications

Author(s): Kristina Živojević, Minja Mladenović, Mila Djisalov, Mirjana Mundzic, Eduardo Ruiz-Hernandez, Ivana Gadjanski, Nikola Ž. Knežević
Published in: Journal of Controlled Release, Issue 337, 2021, Page(s) 193-211, ISSN 0168-3659
Publisher: Elsevier BV
DOI: 10.1016/j.jconrel.2021.07.029

Biocompatible copolymer formulations to treat glioblastoma multiforme

Author(s): Luiza C.S. Erthal, Oliviero L. Gobbo, Eduardo Ruiz-Hernandez
Published in: Acta Biomaterialia, Issue 121, 2021, Page(s) 89-102, ISSN 1742-7061
Publisher: Elsevier BV
DOI: 10.1016/j.actbio.2020.11.030

Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer

Author(s): Marina Martínez-Carmona, Quy P. Ho, Jérémy Morand, Ana García, Enrique Ortega, Luiza C. S. Erthal, Eduardo Ruiz-Hernandez, M. Dolores Santana, José Ruiz, Maria Vallet-Regí, Yurii K. Gun’ko
Published in: Inorganic Chemistry, Issue 59/14, 2020, Page(s) 10275-10284, ISSN 0020-1669
Publisher: American Chemical Society
DOI: 10.1021/acs.inorgchem.0c01436